Genoway SA
PAR:ALGEN

Watchlist Manager
Genoway SA Logo
Genoway SA
PAR:ALGEN
Watchlist
Price: 2.35 EUR Market Closed
Market Cap: 22.3m EUR

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Genoway SA

Revenue
22.1m EUR
Cost of Revenue
-1.5m EUR
Gross Profit
20.6m EUR
Operating Expenses
-18.8m EUR
Operating Income
1.8m EUR
Other Expenses
18.5k EUR
Net Income
1.8m EUR

Margins Comparison
Genoway SA Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
FR
Genoway SA
PAR:ALGEN
20.4m EUR
93%
8%
8%
FR
Pharnext SCA
OTC:PNEXF
6T USD
0%
-17 527%
-21 040%
US
Abbvie Inc
NYSE:ABBV
412.2B USD
71%
33%
4%
US
Amgen Inc
NASDAQ:AMGN
180.9B USD
72%
34%
19%
US
Gilead Sciences Inc
NASDAQ:GILD
153.3B USD
79%
39%
28%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
110.3B USD
86%
39%
31%
US
Epizyme Inc
F:EPE
94.1B EUR
76%
-370%
-392%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
71.8B USD
86%
28%
32%
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
59.3B USD
84%
-7%
-13%
AU
CSL Ltd
ASX:CSL
87.6B AUD
52%
26%
19%
NL
argenx SE
XBRU:ARGX
47.6B EUR
90%
22%
43%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Genoway SA Competitors

Country Company Market Cap ROE ROA ROCE ROIC
FR
Genoway SA
PAR:ALGEN
20.4m EUR
10%
6%
8%
6%
FR
Pharnext SCA
OTC:PNEXF
6T USD
115%
-391%
275%
3 093%
US
Abbvie Inc
NYSE:ABBV
412.2B USD
139%
2%
20%
28%
US
Amgen Inc
NASDAQ:AMGN
180.9B USD
82%
8%
17%
15%
US
Gilead Sciences Inc
NASDAQ:GILD
153.3B USD
41%
14%
25%
19%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
110.3B USD
22%
16%
23%
25%
US
Epizyme Inc
F:EPE
94.1B EUR
-877%
-67%
-73%
-182%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
71.8B USD
15%
12%
11%
12%
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
59.3B USD
-258%
-7%
-6%
-10%
AU
CSL Ltd
ASX:CSL
87.6B AUD
16%
8%
12%
10%
NL
argenx SE
XBRU:ARGX
47.6B EUR
30%
26%
15%
61%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less